Skip to main content
Clinical Trials/KCT0003058
KCT0003058
Active, not recruiting
未知

A retrospective, observational study to evaluate the effectiveness of Carnitine complex (GODEX®) in patients with nonalcoholic fatty liver disease.

Celltrion Pharm0 sites30 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Celltrion Pharm
Enrollment
30
Status
Active, not recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Observational Study
Sex
All

Investigators

Sponsor
Celltrion Pharm

Eligibility Criteria

Inclusion Criteria

  • 1\. 19 \~70 years old (Adult over 19 under the age of 70\)
  • 2\. Subjects who were diagnosed with NAFLD
  • 3\. If treated group, subjects who were treated with carnitine complex (824mg PO, TID) for at least 24 weeks form index date
  • 4\. If control group, subjects who were not taking hepatotonic medications at least 24 weeks from index dates

Exclusion Criteria

  • 1\. Chronic alcoholic disease
  • 2\. Acute hepatitis A, Viral liver disease, drug induced liver disease, biliary obstruction (Chronic hepatitis B patients without taking antiviral agent are eligible)
  • 3\. Subjects who administered oral hypoglycemic agent including insulin.
  • 4\. Subjects who administered hyperlipidemia medication, antiobestic medication
  • 5\. Subjects who administered hepatotonics except for carnitine complex (Godex cap.)
  • 6\. Subjects with progressive diseases such as malignant tumor
  • 7\. Subjects accompanying active hemorrhage
  • 8\. Other subjects who are not eligible for this study

Outcomes

Primary Outcomes

Not specified

Similar Trials